EASE Trial: New Stents for Emphysema
Author Information
Author(s): Pallav L Shah, Dirk-Jan Slebos, Paulo FG Cardoso, Edward J Cetti, Gerhard W Sybrecht, Joel D Cooper
Primary Institution: Royal Brompton Hospital, Imperial College London
Hypothesis
Can Exhale® Drug-Eluting Stents improve pulmonary function and reduce breathlessness in patients with severe hyperinflation due to emphysema?
Conclusion
The EASE Trial aims to determine if a new bronchoscopic procedure can help emphysema patients breathe better and feel less short of breath.
Supporting Evidence
- Over 3.7 million adults in the US are diagnosed with emphysema.
- The trial uses Bayesian statistics for sample size determination.
- Subjects undergo 16-20 sessions of supervised pulmonary rehabilitation before randomization.
- Safety and effectiveness endpoints are measured at 6 months post-procedure.
- Previous studies showed significant improvements in pulmonary function with stent placement.
Takeaway
Doctors are testing a new way to help people with a serious lung disease feel better by using special stents to open up their airways.
Methodology
A multi-center, randomized, double-blind, sham-controlled trial with 225 to 450 subjects receiving either the stent or sham treatment.
Potential Biases
The randomization ratio may introduce a placebo effect.
Limitations
Potential electrical interference from devices like pacemakers may exclude some patients.
Participant Demographics
Subjects are adults aged 35 and older with severe homogeneous emphysema.
Statistical Information
P-Value
p = 0.04
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website